Susan Hurley1, Debbie Goldberg2, June-Soo Park3, Myrto Petreas3, Leslie Bernstein4, Hoda Anton-Culver5, Susan L Neuhausen4, David O Nelson6, Peggy Reynolds7. 1. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Cancer Prevention Institute of California, Berkeley, CA, USA. Electronic address: Susan.Hurley@ucsf.edu. 2. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Cancer Prevention Institute of California, Berkeley, CA, USA. 3. Environmental Chemistry Laboratory, Department of Toxic Substances Control, Berkeley, CA, USA. 4. Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. 5. Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, CA, USA. 6. Cancer Prevention Institute of California, Berkeley, CA, USA. 7. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Cancer Prevention Institute of California, Berkeley, CA, USA; Stanford University School of Medicine, Department of Health Research and Policy, Stanford, CA, USA.
Abstract
PURPOSE: Polybrominated diphenyl ethers (PBDEs) are among the most persistent and pervasive global environmental contaminants. Their toxic and endocrine-disrupting properties have made them a focus of concern for breast cancer. Our objective was to evaluate the risk of breast cancer associated with serum PBDE levels in a case-control study nested within the California Teachers Study. METHODS: Participants were 902 women with invasive breast cancer (cases) and 936 with no such diagnosis (controls) who provided 10 mL of blood and were interviewed between 2011 and 2015. Blood samples were collected from cases an average of 35 months after diagnosis. PBDEs were measured in serum using automated solid phase extraction and gas chromatography/high resolution mass spectrometry. Statistical analyses were restricted to the three congeners with detection frequencies ≥75%: 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), 2,2',4,4',6-pentabromodiphenyl ether (BDE-100), and 2,2',4,4',5,5'-hexabromodiphenyl ether (BDE-153). Unconditional logistic regression was used to estimate multivariable-adjusted odds ratios (ORs) and their 95% confidence intervals (CI) for each BDE congener, adjusting for serum lipids and other potential confounders. RESULTS: The OR for each of the three BDE congeners was close to unity with a CI that included one. Analyses stratified by menopausal status, tumor hormone responsiveness, BMI, and changes in body weight yielded similarly null results. CONCLUSIONS: Our findings provide no evidence that serum levels of BDE-47, BDE-100 or BDE-153 are associated with breast cancer risk. These results should be interpreted in the context of study limitations which include the reliance on PBDE measurements that may not represent pre-diagnostic, early-life or chronic exposures and a lack of information on genetic polymorphisms and other factors which may affect endogenous estrogen levels.
PURPOSE:Polybrominated diphenyl ethers (PBDEs) are among the most persistent and pervasive global environmental contaminants. Their toxic and endocrine-disrupting properties have made them a focus of concern for breast cancer. Our objective was to evaluate the risk of breast cancer associated with serum PBDE levels in a case-control study nested within the California Teachers Study. METHODS:Participants were 902 women with invasive breast cancer (cases) and 936 with no such diagnosis (controls) who provided 10 mL of blood and were interviewed between 2011 and 2015. Blood samples were collected from cases an average of 35 months after diagnosis. PBDEs were measured in serum using automated solid phase extraction and gas chromatography/high resolution mass spectrometry. Statistical analyses were restricted to the three congeners with detection frequencies ≥75%: 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), 2,2',4,4',6-pentabromodiphenyl ether (BDE-100), and 2,2',4,4',5,5'-hexabromodiphenyl ether (BDE-153). Unconditional logistic regression was used to estimate multivariable-adjusted odds ratios (ORs) and their 95% confidence intervals (CI) for each BDE congener, adjusting for serum lipids and other potential confounders. RESULTS: The OR for each of the three BDE congeners was close to unity with a CI that included one. Analyses stratified by menopausal status, tumor hormone responsiveness, BMI, and changes in body weight yielded similarly null results. CONCLUSIONS: Our findings provide no evidence that serum levels of BDE-47, BDE-100 or BDE-153 are associated with breast cancer risk. These results should be interpreted in the context of study limitations which include the reliance on PBDE measurements that may not represent pre-diagnostic, early-life or chronic exposures and a lack of information on genetic polymorphisms and other factors which may affect endogenous estrogen levels.
Authors: Andreas Sjödin; Lee-Yang Wong; Richard S Jones; Annie Park; Yalin Zhang; Carolyn Hodge; Emily Dipietro; Cheryl McClure; Wayman Turner; Larry L Needham; Donald G Patterson Journal: Environ Sci Technol Date: 2008-02-15 Impact factor: 9.028
Authors: Thao T Vo; Beth C Gladen; Glinda S Cooper; Donna D Baird; Julie L Daniels; Marilie D Gammon; David B Richardson Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-10 Impact factor: 4.254
Authors: Chris E Talsness; Sergio N Kuriyama; Anja Sterner-Kock; Petra Schnitker; Simone Wichert Grande; Mehdi Shakibaei; Anderson Andrade; Konstanze Grote; Ibrahim Chahoud Journal: Environ Health Perspect Date: 2008-03 Impact factor: 9.031
Authors: Jay H Lubin; Joanne S Colt; David Camann; Scott Davis; James R Cerhan; Richard K Severson; Leslie Bernstein; Patricia Hartge Journal: Environ Health Perspect Date: 2004-12 Impact factor: 9.031
Authors: Mary H Ward; Joanne S Colt; Nicole C Deziel; Todd P Whitehead; Peggy Reynolds; Robert B Gunier; Marcia Nishioka; Gary V Dahl; Stephen M Rappaport; Patricia A Buffler; Catherine Metayer Journal: Environ Health Perspect Date: 2014-06-03 Impact factor: 9.031
Authors: Eunjung Lee; April Kinninger; Giske Ursin; Chiuchen Tseng; Susan Hurley; Miaomiao Wang; Yunzhu Wang; June-Soo Park; Myrto Petreas; Dennis Deapen; Peggy Reynolds Journal: Int J Environ Res Public Health Date: 2020-01-17 Impact factor: 3.390